Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,700,129
-
Share change
-
-579,402
-
Total reported value
-
$66,119,789
-
Put/Call ratio
-
209%
-
Price per share
-
$2.79
-
Number of holders
-
58
-
Value change
-
-$7,631,209
-
Number of buys
-
40
-
Number of sells
-
21
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q2 2018
As of 30 Jun 2018,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,700,129 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, BlackRock Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP, Hillhouse Capital Management, Ltd., FIL Ltd, BAILARD, INC., and Rock Springs Capital Management LP.
This page lists
58
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.